Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123320004 | 12332000 | 4 | F | 201510 | 20160902 | 20160504 | 20160907 | EXP | US-PFIZER INC-2016242032 | PFIZER | 67.00 | YR | F | Y | 85.00000 | KG | 20160907 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123320004 | 12332000 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Vaginal | 1 G, 2X/WEEK | 20216 | 1 | G | VAGINAL CREAM | BIW | ||||||
| 123320004 | 12332000 | 2 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Vaginal | 10 MG, 2X/WEEK | L61826 | 20216 | 10 | MG | VAGINAL CREAM | BIW | |||||
| 123320004 | 12332000 | 3 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK | 0 | |||||||||||
| 123320004 | 12332000 | 4 | C | ATENOLOL. | ATENOLOL | 1 | UNK | 0 | |||||||||||
| 123320004 | 12332000 | 5 | C | EVISTA | RALOXIFENE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 123320004 | 12332000 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 123320004 | 12332000 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 123320004 | 12332000 | 8 | C | MELOXICAM. | MELOXICAM | 1 | UNK | 0 | |||||||||||
| 123320004 | 12332000 | 9 | C | LORATADINE. | LORATADINE | 1 | UNK | 0 | |||||||||||
| 123320004 | 12332000 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123320004 | 12332000 | 1 | Vulvovaginal dryness |
| 123320004 | 12332000 | 2 | Atrophic vulvovaginitis |
| 123320004 | 12332000 | 3 | Anxiety |
| 123320004 | 12332000 | 4 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123320004 | 12332000 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123320004 | 12332000 | Pre-existing condition improved | |
| 123320004 | 12332000 | Therapeutic response unexpected | |
| 123320004 | 12332000 | Urinary tract infection | |
| 123320004 | 12332000 | Urine odour abnormal | |
| 123320004 | 12332000 | Vulval disorder | |
| 123320004 | 12332000 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123320004 | 12332000 | 1 | 201509 | 0 | ||
| 123320004 | 12332000 | 2 | 20151015 | 0 |